MEI Pharma Q1 EPS $8.46 Beats $(2.12) Estimate, Sales $65.30M Up From $8.73M YoY
Portfolio Pulse from Benzinga Newsdesk
MEI Pharma reported Q1 earnings of $8.46 per share, beating the analyst consensus estimate of $(2.12) by 499.06%. This is a 425.38% increase from the same period last year. However, the company's sales this quarter were $752.00K, a 91.39% decrease from $8.73M the same period last year.
November 09, 2023 | 10:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
MEI Pharma's Q1 earnings significantly exceeded estimates, but sales fell sharply compared to the same period last year.
While the company's earnings beat is a positive sign, the sharp decrease in sales could be a concern for investors, potentially leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100